Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your primary ...

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...

The healthcare giant is dealing with the fast-approaching patent cliff for its most important product, cancer medicine ...

Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential ...

As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

Global pharmaceutical company Merck (NYSE:MRK) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with ...

India], January 4: Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks 'World Cancer Day 2025' together with ...

The phase 3 HYPERION trial of Winrevair in adults with newly diagnosed pulmonary arterial hypertension functional class two ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the Phase 3 HYPERION study evaluating ...

BusinessWire India Accra [Ghana] Mumbai Maharashtra [India] January 31 Senator Dr Rasha Kelej CEO of Merck Foundation and ...

The healthcare pioneer shares insights on transformative diagnostics where precision medicine meets women’s health innovation ...